AI Verdict
KNSA has stronger fundamentals based on our AI analysis.
KNSA vs KMTS Fundamental Comparison
| Metric | KNSA | KMTS |
|---|---|---|
| Revenue | $677.6M | $66.5M |
| Net Income | $59.0M | $-92.8M |
| Net Margin | 8.7% | -139.5% |
| ROE | 10.4% | -32.2% |
| ROA | 7.7% | -24.5% |
| Current Ratio | 3.79x | 7.32x |
| Debt/Equity | 0.00x | 0.15x |
| EPS | $0.75 | $-1.76 |
Green = Better metric | Red = Weaker metric
You Might Also Compare
KNSA vs KMTS: Frequently Asked Questions
Is KNSA or KMTS a better buy in 2026?
Based on dual AI fundamental analysis (Claude and ChatGPT), KNSA has stronger fundamentals. KNSA is rated HOLD (68% confidence) while KMTS is rated HOLD (55% confidence). This is not investment advice.
How does KNSA compare to KMTS fundamentally?
Kiniksa Pharmaceuticals International, plc has ROE of 10.4% vs KESTRA MEDICAL TECHNOLOGIES, LTD.'s -32.2%. Net margins are 8.7% vs -139.5% respectively.
Which stock pays higher dividends, KNSA or KMTS?
KNSA has a dividend yield of N/A or no dividend while KMTS has N/A or no dividend. Check individual stock pages for detailed dividend history and payout ratios.
Should I invest in KNSA or KMTS for long term?
For long-term investing, consider that KNSA has HOLD rating with 68% confidence, while KMTS has HOLD rating with 55% confidence. Higher confidence indicates more consistent fundamentals from SEC filings. This is not investment advice - always do your own research.
What do the AI models say about KNSA vs KMTS?
Our dual AI system (Claude by Anthropic and ChatGPT by OpenAI) analyzes SEC 10-K and 10-Q filings independently. For KNSA vs KMTS, the AI consensus favors KNSA based on fundamental metrics including revenue growth, profitability, ROE, and balance sheet strength.